How our AI Engines Free Drug Hunters from Granting IP Co-Ownership

Logic Behind Conventional Methodology


Drug hunters create hypotheses from targets and design bioassays to test the hypotheses.

Accordingly, co-development with AI platform providers necessitates disclosure of the target, the hypothesis, and sharing of the prospective intellectual property ownership.

Keff target illustration

From Statistical Profiling to Comprehensive Prediction


Our predictive intelligence engine observes the bioassay statistics, derives equations from the observations like a physicist, and does not rely on target hypotheses.

As a consequence, target disclosure is no longer required. So—please do not disclose to us!

Keff target illustration